Back to Find a Doctor
Dr. Neela D. Goswami

Dr. Neela D. Goswami, MD, MPH

Dr. Neela D. Goswami received a BS with honors in biology from Stanford University, a medical degree from the Johns Hopkins School of Medicine, and an MPH from the University of North Carolina, Chapel Hill. She completed an internal medicine residency and infectious diseases fellowship at Duke University Medical Center and worked as an attending physician at the Durham VA Medical Center. She moved with her family to Atlanta, Georgia to join faculty at the Emory School of Medicine and Rollins School of Public Health and work as an infectious diseases physician. She also works in the Field Services Branch of the Division of Tuberculosis Elimination at the Centers for Disease Control and Prevention. During the COVID-19 pandemic, she served in the CDC COVID-19 Response Health Systems and Worker Safety Task Force and CDC COVID-19 Vaccine Task Force. She enjoys working with medical students, residents, and fellows. Her clinical interests include TB and HIV/AIDS. She has a keen interest in bringing the latest clinical advancements to patient care.


  • Infectious Disease

Board Certifications

  • ABMS Internal Medicine


  • Duke University Medical Center


  • Emory

Education & Training

  • Medical School: John Hopkins University School of Medicine
  • Residency: Duke University Medical Center

Honors & Awards

Harry C. Saltzstein Prize, Medical Writing, Johns Hopkins School of Medicine, 2005

Barton Haynes Research Award, Duke University Medical Center, 2007

Robert M. Califf Research Award, Duke University Medical Center, 2009

Appleseed Housestaff Teaching Award, Duke University School of Medicine, 2009

Infectious Diseases Society of America (IDSA) Travel Award, 2011

On the Spot Award, Centers for Disease Control and Prevention, 2017

CDC National Center for HIV/AIDS, Hepatitis, STDs and Tuberculosis Award for Excellence in Program Delivery, COVID-Domestic, 2021

CDC National Center for HIV/AIDS, Viral Hepatitis, STD and TB Director's Recognition Award, 2022


Mermelstein PG, Deisseroth K, Dasgupta N, Isaksen A, Tsien RW. Calmodulin priming: Nuclear translocation of a calmodulin complex and the memory of prior neuronal activity. PNAS 2001 98:26.

Dasgupta N, Fine D. Case Report: Central nervous lymphoma in a patient with systemic lupus erythematosus. Lupus June 2005, Vol 14.

Ziegelstein RC, Meuchel J, Kim TJ, Latif M, Alvarez W, Dasgupta N, Thombs BD. Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med. 2007 Jun;120(6):525-30.

Dasgupta N. Unclaimed bodies at the anatomy table. JAMA 2004 Jan; 291(1): 122.

Person AK, Goswami ND, Bissette DJ, Turner DS, Baker AV, Gadkowski LB, Naggie S, Erlandson K, Chen L, Lalani T, Cox GM, Stout JE. Pairing Quantiferon Gold In-tube with Opt-out HIV Testing in a TB Contact Investigation: A Potent Strategy. AIDS Patient Care STDS. 2010 Sep;24(9):539-43.

Goswami ND, Shah JJ, Corey GR, Stout JE. Persistent Eosinophilia and Strongyloides Infection in Montagnard Refugees after Presumptive Albendazole Therapy. American Journal of Tropical Medicine and Hygiene 2009 Aug;81(2):302-4.

Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, Cadogan E, Nahid P, Ferrari G, Stout JE. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis 2011 May;91(3):250-6.

Wang D, Hicks CB, Goswami ND, Tafoya E, Ribeiro RM, Cai F, Perelson AS, Gao F. Evolution of drug-resistant viral populations during interruption of antiretroviral therapy. J Virol. 2011 Jul;85(13):6403-15.

Goswami ND, Johnson MD, Chu V. Ertapenem for Treatment of Osteomyelitis: A Case Series. BMC Research Notes 2011, 4:478 (2 November 2011).

Goswami ND, Hecker E, Holland DP, Naggie S, Cox GM, Mosher A, Turner D, Torres Y, Ahearn MA, Blain ML, Rasmussen P, Vickery C, Stout JE. Feasibility and willingness-to-pay for integrated community-based tuberculosis testing. BMC Infect Dis. 2011 Nov 2;11:305.

Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blaim MLM, Ostbye T, Saukkonen J, Stout JE. Predictors of Latent Tuberculosis Treatment Initiation and Completion at a U.S. Public Health Clinic: A Prospective Cohort Study. BMC Public Health, 2012 Jun 21;12(1):468.

Bowman N, Goswami ND, Lippincott CK, Vinikoor MJ, Miller WC. Clinical scoring for risk of resistant organisms in pneumonia: Right idea, wrong interpretation. Clinical Infectious Diseases, 2012 Sep;55(5):749-50.

Goswami ND, Hecker EJ, Vickery C, Ahearn MA, Cox GM, Holland DP, Naggie S, Piedrahita C, Mosher A, Torres Y, Norton BL, Suchindran S, Park PH, Turner D, Stout JE. Geographic Information System-based Screening for TB, HIV, and Syphilis (GIS-THIS): A Cross-Sectional Study. PLOS One, 2012;7(10):e46029.

Park PH, Holland DP, Wade A, Goswami ND, Bissette D, Stout JE. Public health costs for Tuberculosis suspects in Wake County, North Carolina. Int J Tuberc Lung Dis. 2013 Jun;17(6):759-63.

Goswami ND, Stout JE, Miller WC, Hecker EJ, Cox GM, Norton BL, Sena AC. The Footprint of Old Syphilis: Using a Reverse Screening Algorithm for Syphilis Testing in a U.S. Geographic Information Systems-Based Community Outreach Program. Sex Transm Dis. 2013 Nov;40(11):839-41.

Goswami ND, Pfeiffer CD, Horton JR, Chiswell K, Tasneem A, Tsalik EL. The State of Infectious Diseases Clinical Trials: A Systematic Review of PLoS One. 2013 Oct 16;8(10):e77086.

Stout JE, Katrak S, Goswami ND, Norton BL, Fortenberry ER, Foust E, Leone P. Integrated Screening for Tuberculosis, Human Immunodeficiency Virus, and Syphilis in Tuberculosis Contact Investigations: Lessons Learned in North Carolina. Public Health Rep. 2014 Jan-Feb;129 Suppl 1:21-5.

Goswami ND, Tsalik EL, Naggie S, Miller WC, Horton JR, Pfeiffer CD, Hicks CB. A cross-sectional analysis of HIV & hepatitis C clinical trials 2007-2010: The relationship between industry sponsorship and randomized study design. Trials. 2014 Jan 22;15:31.

Norton BL, Timberlake SH, Hecker EJ, Goswami ND, Huffman KM, Landgraf A, Voils CI, Naggie S, Stout JE. Community Knowledge and Attitudes Regarding Hepatitis C Disease, Testing, and Treatment in a High-risk Urban Population. BMC Infect Dis. 2014 Feb 10;14(1):74.

Goswami ND, Schmitz M, Sanchez T, Dasgupta S, Sullivan PS, Cooper HL, Rane D, Kelly J, del Rio C, Waller, L. Understanding Local Spatial Variation along the Care Continuum: The Potential Impact of Transportation Vulnerability on HIV Linkage to Care and Viral Suppression in High-Poverty Areas, Atlanta, Georgia. J Acquir Immune Defic Syndr. 2015 Dec 1.

Phadke VK, Hirsh DS, Goswami ND. Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation. Emerging Infectious Diseases. 2016 March; 22(3): 389-95.

Colasanti J, Goswami ND, Khoubian JJ, Pennisi E, Root C, Zeimer D, Armstrong WS, del Rio C. The Perilous Road from HIV Diagnosis in the Hospital to Viral Suppression in the Clinic. AIDS Research and Human Retroviruses. 2016 Aug;32(8):729-36.

Nandi P, Worrell MC, Andrews T, Sales RM, McMichael J, Hampton KH, Goswami, ND. Engaging Homeless Service Providers in Educational Efforts During a Tuberculosis Outbreak in Atlanta. J Ga Public Health Assoc (2016), Supplement to Vol. 6 (2).

Worrell MC; Kramer M; Yamin A; Ray SM; Goswami ND. Use of Activity Space in a Tuberculosis Outbreak: Bringing Homeless Persons into Spatial Analyses. Open Forum Infectious Diseases 2017 Jan 9;4(1).

Goswami ND, Colasanti J, Khoubian JJ, Huang Y, Armstrong WS, Del Rio C. A Minority of Patients Newly Diagnosed with AIDS Are Started on Antiretroviral Therapy at the Time of Diagnosis in a Large Public Hospital in the Southeastern United States. J Int Assoc Provid AIDS Care. 2017 Jan 1.

Haley DF, Haardörfer R, Kramer MR, Adimora AA, Wingood GM, Goswami ND, Rubtsova A, Ludema C, Hickson DA, Ramirez C, Ross Z, Bolivar H, Cooper HLF. Associations between Neighborhood Characteristics and Sexual Risk Behaviors among HIV-infected and HIV-uninfected Women in the Southern United States. Annals of Epidemiology May 2017.

Connors WJ, Hussen SA, Holland DP, Mohamed O, Andes KL, Goswami ND. Homeless shelter context and tuberculosis illness experiences during a large outbreak in Atlanta, Georgia. Public Health Action. 2017 Sep 21;7(3):224-230.

Patel AS, Gellar R, Goswami ND. Plasma cell variant multicentric Castleman disease and Kaposi's sarcoma in a treatment-naïve HIV-infected patient. Accepted to AIDS Research and Human Retroviruses, November 2017.

Haley DF, Wingood GM Kramer MR, Haardörfer R, Adimora AA, Goswami ND, Rubtsova A, Ludema C, Hickson DA, Ramirez C, Ross Z, Bolivar H, Cooper HLF. Associations Between Neighborhood Characteristics, Social Cohesion, and Perceived Sex Partner Risk among HIV-seropositive and HIV-seronegative Women in the Southern United States. Arch Sex Behav. 2018, epub ahead of print. doi: 10.1007/s10508-018-1205-8.

Notes from the Field: Acquisition of delamanid under a compassionate use program for extensively drug-resistant tuberculosis - United States, 2017. Lardizabal AA, Khan AN, Morris SB, Goswami ND. MMWR Weekly 67(35): 996-997;Sept 7, 2018.

Holland DP, Alexander S, Onwubiko U, Goswami ND, Yamin A, Mohamed O, et al. Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017. Emerg Infect Dis. March 2019;25(3):593-595.

Goswami ND, Mase S, Griffith D, Bhavaraju R, Lardizabal A, Lauzardo M, Chen L, Wilson J, Chappelle C, Haley CA. Tuberculosis in the United States: Medical Consultation Services Provided by Five TB Regional Training and Medical Consultation Centers, 2013-2017. Open Forum Infectious Diseases, 6(6):1-3; April 4, 2019. Selected for inclusion in the online "Tuberculosis Collection," a special collection of Open Forum Infectious Diseases articles focused on the diagnosis, treatment and impact of tuberculosis

Belanger A, Morris SB, Brostrom R, Yost D, Goswami ND, Oxtoby M, Moore M, Westenhouse J, Barry PB, Shah S. Introduction and Evaluation of Multidrug-Resistant Tuberculosis Supplemental Surveillance in the United States. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 15, May 2019.

Sosa LE, Njie GJ, Lobato MN, Morris SB, Buchta W, Casey ML, Goswami ND, Gruden MA, Hurst BJ, Khan AR, Kuhar DT, Lewinsohn DM, Mathew TA, Mazurek GH, Reves R, Paulos L, Thanassi W, Will L, Belknap R. Tuberculosis Screening, Testing, and Treatment of U.S. Health-Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Weekly 68(19): 439-443; May 2019.

Imada EK, MPH, Roberson EK, PhD, Moser K, Goswami ND, Tardivel K. "Notes from the Field: Meningeal and Pulmonary TB on a Commercial Fishing Vessel - Hawaii, 2017. MMWR Weekly, June 21, 2019.

Gobaud A, Haley CA, Wilson JW, Bhavaraju R, Lardizabal A, Seaworth B, Goswami ND. "Multidrug-Resistant Tuberculosis Care in the United States: A Summary of Medical Consultations." IJTLD, April 1, 2020.

Kerr EK, Vonnahme LA, Goswami ND. "Measuring the Impact of Targeted Local Interventions on Tuberculosis Awareness and Screening among Persons Experiencing Homelessness during a Large Tuberculosis Outbreak, 2015-2016." Public Health Reports, 135(1): 90S-99S, July 31, 2020.

Fernando R, Bhavaraju R, Fraimow H, Wilson JW, Armitige L, Haley C, and Goswami ND. "A Model for Bringing TB Expertise to HIV Providers: Medical Consultations to the CDC-Funded Regional Tuberculosis Training and Medical Consultation Centers, 2013-2017." PLOS One, 2020 Aug 31;15(8):e0236933. Selected as featured publication for online October 2020 NCHHSTP Director's Update

McDowell A, Haas M, Seaworth B, Wilson JW, Haley C, Patrawalla A, Lauzardo M, and Goswami ND. "Linezolid Use for the Treatment of Multidrug-Resistant Tuberculosis, TB Centers of Excellence, United States, 2013-2018." J Clin Tuberc Other Mycobact Dis. 2020 Nov 16;22:100201.

Haley CA, Macias P, Jasuja S, Jones BA, Rowlinson MC, Jaimon R, Onderko P, Darnall E, Gomez ME, Peloquin C, Ashkin D, Goswami ND. "First U.S. Patient Treated with a Novel Six-month Treatment Regimen including Bedaquiline, Linezolid, and Pretomanid ("BPaL") for Drug-Resistant Tuberculosis - United States, 2019-2020." Emerg Infect Dis. 2021;27(1):332-334.

Goswami ND, Fiore AE, Walke HT. Evidence, Experience, Expertise, and the US Coronavirus Disease 2019 Public Health Response. Clinical Infectious Diseases, Volume 73, Issue Supplement_1, 15 July 2021, Pages S1-S4,

Narita M, Hatt G, Toren KG, Vuong K, Pecha M, Jereb JA, Goswami ND. Delayed Tuberculosis Diagnoses During the Coronavirus Disease 2019 (COVID-19) Pandemic in 2020-King County, Washington. Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S74-S76.

Agathis NT, Bhavaraju R, Shah V, Chen L, Haley CA, Goswami ND, Patrawalla A. Challenges in latent tuberculosis infection (LTBI) care throughout the United States identified through a nationwide TB medical consultation database. Public Health Action, September 2021.

Katrak S, Probst JR, Reynolds S, Marks SM, Castro KG, Chorba T, Goswami ND. Clinical Characteristics and Outcomes of TB Cases Treated with TNF-alpha Inhibitors in the U.S., 2011-2015. Open Forum Infectious Diseases, September 2021.

Mbaeyi S, Oliver SE, Chamberland M, Collins JP, Godfrey, Goswami ND, Hadler SC, Jones J, Moline H, Moulia D, Reddy S, Schmit K, Wallace M, Campos-Outcalt D, Morgan RL, Bell BP, Brooks O, Kotton C, Talbot K, Lee G, Daley MF, Dooling K. "The Advisory Committee on Immunization Practices' Interim Recommendations for Additional and Booster Doses of COVID-19 Vaccines - United States, 2021." MMWR November 5, 2021 / 70(44);1545-1552.

Goswami ND, Peddareddy LP, Jereb J, Semidey AC, Darnall E, Macias P, Jasuja S, Landers K, Dasgupta S, Oxtoby M, Spitters C, Dov L, Narita M, DaSilva M, Cropper T, Gullickson C, Ashkin DA, Haley C. "Pretomanid in the Treatment of Patients with Tuberculosis in the United States: the Bedaquiline, Pretomanid and Linezolid (BPaL) Accelerated Monitoring (BAM) Project." Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S784 S785

Burzynski J, Mangan JM, Lam CK, Macaraig M, Salerno MM, Rey de Castro, Goswami ND, Lin CY, Schluger NW, Vernon A, and the eDOT Study Team. "Traditional, in-person directly observed therapy (DOT) versus electronic DOT for tuberculosis (TB) treatment: A randomized clinical trial." JAMA Netw Open. 2022;5(1):e2144210. doi:10.1001/jamanetworkopen.2021.44210

Carr W, Kurbatova E, Starks A, Goswami ND, Allen L, Winston C. "Four-month rifapentine-moxifloxacin regimen for the treatment of drug-susceptible pulmonary tuberculosis (TB) - Interim CDC Guidance, United States, 2022." MMWR February 25, 2022 / 71(8);285-289